As a contract development and manufacturing organization (CDMO), GVB is believed to be one of the largest providers of hemp-derived active ingredients for the pharmaceutical and consumer goods industries worldwide based on total tonnage. GVB is at the vanguard of the organic cultivation, research, development, and marketing of hemp-based wellness solutions for suppliers, customers, and consumers around the globe. Due to GVB’s lower cost technology, it has become a market leading source of CBD active ingredients and private label manufacturing for retailers and marketers. GVB believes it possesses low-cost custom infrastructure and durable competitive technological advantages that have allowed it to scale quickly.
Acquired by 22nd Century (Nasdaq: XXII)